Efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory ankylosing spondylitis
Author(s) -
Shengli Zhang,
Zhihan Chen,
Yanfang Wu,
Diantian Lin,
Juanjuan He,
Jianwen Liu,
Fei Gao,
He Lin
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-19-409
Subject(s) - medicine , ankylosing spondylitis , basdai , basfi , refractory (planetary science) , thalidomide , adverse effect , physical therapy , disease , physics , astrobiology , multiple myeloma , psoriatic arthritis
Thalidomide has been used to treat ankylosing spondylitis (AS) patients, but the efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory AS has not been evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom